Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rgnull RIP-DTR mice engrafted with human islets
Published inDiabetes, metabolic syndrome and obesity, vol. 8, p. 387-398
Publication date2015
Affiliation entities
Research groups
Citation (ISO format)
BORTELL, Rita et al. Lixisenatide accelerates restoration of normoglycemia and improves human beta-cell function and survival in diabetic immunodeficient NOD-scid IL-2rgnull RIP-DTR mice engrafted with human islets. In: Diabetes, metabolic syndrome and obesity, 2015, vol. 8, p. 387–398. doi: 10.2147/DMSO.S87253
Main files (1)
Article (Submitted version)
Identifiers
- PID : unige:80783
- DOI : 10.2147/DMSO.S87253
- PMID : 26316789
Additional URL for this publicationhttp://www.dovepress.com/lixisenatide-accelerates-restoration-of-normoglycemia-and-improves-hum-peer-reviewed-article-DMSO
Journal ISSN1178-7007